國立高雄大學圖資館 |

Language: English

Back

Biosimilars for cancer treatmenta promising approach /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Biosimilars for cancer treatmentedited by Shvetank Bhatt ... [et al.].
Reminder of title:	a promising approach /
other author:	Bhatt, Shvetank.
Published:	Singapore :Springer Nature Singapore :2024.
Description:	xvi, 309 p. :ill. (chiefly col.), digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	CancerChemotherapy.
Online resource:	https://doi.org/10.1007/978-981-97-3001-8
ISBN:	9789819730018$q(electronic bk.)

Biosimilars for cancer treatmenta promising approach /
Biosimilars for cancer treatmenta promising approach /[electronic resource] :edited by Shvetank Bhatt ... [et al.]. - Singapore :Springer Nature Singapore :2024. - xvi, 309 p. :ill. (chiefly col.), digital ;24 cm.

1. An Overview of Biosimilars -- 2. Immunobiology of Cancer -- 3. Mechanism of Biosimilars for the treatment of Cancer -- 4. Biosimilars in Colorectal Cancer -- 5. Biosimilars in Cervical Caner -- 6. Biosimilars in Prostate Cancer -- 7. Biosimilars in Gastric Cancer -- 8. Biosimilars in Lung Cancer -- 9. A Recent Overview of The Growing Applications of Biosimilars in Pancreatic Cancer Management- Current Picture and Future Perspectives -- 10. Biosimilars in Breast Cancer -- 11. Biosimilars in Hepatocellular Carcinoma -- 12. Biosimilars in Ovarian Cancer -- 13. Biosimilars in Blood Cancer -- 14. Biosimilars in Clinical Trials -- 15. Regulatory Considerations of Biosimilars in Cancer -- 16. Future Scope of Biosimilars for the Treatment of Various Cancers.

The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.

ISBN: 9789819730018$q(electronic bk.)

Standard No.: 10.1007/978-981-97-3001-8doiSubjects--Topical Terms:

194707
Cancer
--Chemotherapy.

LC Class. No.: RC271.C5

Dewey Class. No.: 616.994061

Biosimilars for cancer treatmenta promising approach /
LDR:02372nmm a2200325 a 4500 001 657960
003 DE-He213
005 20240702131407.0
006 m d
007 cr nn 008maaau
008 240923s2024 si s 0 eng d
020 $a 9789819730018$q(electronic bk.)
020 $a 9789819730001$q(paper)
024 7 $a 10.1007/978-981-97-3001-8 $2 doi
035 $a 978-981-97-3001-8
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.C5
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994061 $2 23
090 $a RC271.C5 $b B616 2024
245 1 0 $a Biosimilars for cancer treatment $h [electronic resource] : $b a promising approach / $c edited by Shvetank Bhatt ... [et al.].
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xvi, 309 p. : $b ill. (chiefly col.), digital ; $c 24 cm.
505 0 $a 1. An Overview of Biosimilars -- 2. Immunobiology of Cancer -- 3. Mechanism of Biosimilars for the treatment of Cancer -- 4. Biosimilars in Colorectal Cancer -- 5. Biosimilars in Cervical Caner -- 6. Biosimilars in Prostate Cancer -- 7. Biosimilars in Gastric Cancer -- 8. Biosimilars in Lung Cancer -- 9. A Recent Overview of The Growing Applications of Biosimilars in Pancreatic Cancer Management- Current Picture and Future Perspectives -- 10. Biosimilars in Breast Cancer -- 11. Biosimilars in Hepatocellular Carcinoma -- 12. Biosimilars in Ovarian Cancer -- 13. Biosimilars in Blood Cancer -- 14. Biosimilars in Clinical Trials -- 15. Regulatory Considerations of Biosimilars in Cancer -- 16. Future Scope of Biosimilars for the Treatment of Various Cancers.
520 $a The book delves into the role of biosimilars in the field of cancer treatment. It also discusses the application of biosimilars in various cancer types, from colorectal and cervical to prostate, gastric, lung, pancreatic, breast, hepatocellular, ovarian, and blood cancers. It contains chapters that focus on the clinical trials of biosimilars, providing insights into the latest research and developments. This book serves as a valuable resource for clinicians, researchers, and anyone seeking a comprehensive understanding of the intersection between biosimilars and cancer treatment.
650 0 $a Cancer $x Chemotherapy. $3 194707
650 0 $a Biopharmaceutics. $3 224951
650 1 4 $a Cancer Biology. $3 920982
650 2 4 $a Biological Sciences. $3 503847
650 2 4 $a Cancer Therapy. $3 915060
650 2 4 $a Cancers. $3 925341
650 2 4 $a Cancer Prevention. $3 965914
650 2 4 $a Cancer Genetics and Genomics. $3 918740
700 1 $a Bhatt, Shvetank. $3 969034
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-3001-8
950 $a Biomedical and Life Sciences (SpringerNature-11642)